**Title: Bioptimus and Proscia Join Forces to Enhance AI-Driven Drug Development and Research**
Bioptimus, a pioneering French startup specializing in AI models for biology, has joined forces with Proscia to propel AI innovation in scientific research and drug development. This strategic collaboration integrates Bioptimus’s advanced H-optimus-0 foundation model into Proscia’s Concentriq® Embeddings, a platform widely used by data scientists and researchers in pathology and life sciences.
The integration promises to significantly enhance the speed and scale of AI-driven developments, providing a robust toolset for tackling complex biological challenges. By incorporating H-optimus-0, researchers can now leverage a more comprehensive collection of foundation models available in the Concentriq suite. This collaboration aims to drive breakthroughs in AI research, ultimately leading to improved patient care through more efficient drug development.
For further details, learn more [here](http://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070).